Infection prevention and control measures


ID:
179

Research Question:
What is the immunogenicity and safety of the influenza vaccine at reduced or regular intradermal doses compared with a full intramuscular dose?

Document Type:
Rapid review

Population:
All populations

Setting:
Community

Public health topic area:
Infection prevention and control measures

Contact Name:
Dr. Fiona Clement

Contact Title:
Director, Health Technology Assessment Unit, University of Calgary

Contact Email:
fclement@ucalgary.ca

Organization:
University of Calgary, Health Technology Assessment Unit

Jurisdiction (of reviewer):
Alberta

Status of Review:
Completed

Review available:
On request

Date Completed:
2020-07-21

Date Submitted:
2020-08-21